Editing Leaky gut

Jump to: navigation, search

Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.

The edit can be undone. Please check the comparison below to verify that this is what you want to do, and then save the changes below to finish undoing the edit.
Latest revision Your text
Line 3: Line 3:
  
 
"Emerging evidence has demonstrated that intestinal homeostasis and the microbiome play essential roles in neurological diseases, such as Parkinson's disease. ... We examined the gut of an ALS mouse model, G93A, which expresses mutant superoxide dismutase (SOD1(G93A)), and discovered a '''damaged tight junction structure and increased permeability with a significant reduction in the expression levels of tight junction protein ZO-1 and the adherens junction protein E-cadherin'''. Furthermore, our data demonstrated '''increased numbers of abnormal Paneth cells''' in the intestine of G93A mice. Paneth cells are specialized intestinal epithelial cells that can sense microbes and secrete antimicrobial peptides, thus playing key roles in host innate immune responses and shaping the gut microbiome. A '''decreased level of the antimicrobial peptides defensin 5 alpha''' was indeed found in the ALS intestine. These changes were associated with a '''shifted profile of the intestinal microbiome, including reduced levels of Butyrivibrio Fibrisolvens, Escherichia coli, and Fermicus''', in G93A mice. '''The relative abundance of bacteria was shifted in G93A mice compared to wild-type''' mice. Principal coordinate analysis indicated a difference in fecal microbial communities between ALS and wild-type mice. Taken together, our study '''suggests a potential novel role of the intestinal epithelium and microbiome in the progression of ALS.'''{{#pmid:    25847918|Wu2015}}  
 
"Emerging evidence has demonstrated that intestinal homeostasis and the microbiome play essential roles in neurological diseases, such as Parkinson's disease. ... We examined the gut of an ALS mouse model, G93A, which expresses mutant superoxide dismutase (SOD1(G93A)), and discovered a '''damaged tight junction structure and increased permeability with a significant reduction in the expression levels of tight junction protein ZO-1 and the adherens junction protein E-cadherin'''. Furthermore, our data demonstrated '''increased numbers of abnormal Paneth cells''' in the intestine of G93A mice. Paneth cells are specialized intestinal epithelial cells that can sense microbes and secrete antimicrobial peptides, thus playing key roles in host innate immune responses and shaping the gut microbiome. A '''decreased level of the antimicrobial peptides defensin 5 alpha''' was indeed found in the ALS intestine. These changes were associated with a '''shifted profile of the intestinal microbiome, including reduced levels of Butyrivibrio Fibrisolvens, Escherichia coli, and Fermicus''', in G93A mice. '''The relative abundance of bacteria was shifted in G93A mice compared to wild-type''' mice. Principal coordinate analysis indicated a difference in fecal microbial communities between ALS and wild-type mice. Taken together, our study '''suggests a potential novel role of the intestinal epithelium and microbiome in the progression of ALS.'''{{#pmid:    25847918|Wu2015}}  
 
"Here we present evidence that '''intestinal dysfunction and dysbiosis may actively contribute to ALS pathophysiology'''... The G93A mice show '''abnormal intestinal microbiome and damaged tight junctions before ALS disease onset'''. The mice were given 2% butyrate, a natural bacterial product, in the drinking water. ... In mice '''fed with butyrate, intestinal microbial homeostasis was restored, gut integrity was improved, and life span was prolonged''' compared with those in control mice. At the cellular level, '''abnormal Paneth cells-specialized intestinal epithelial cells that regulate the host-bacterial interactions-were significantly decreased''' in the ALS mice treated with butyrate. In both ALS mice and intestinal epithelial cells cultured from humans, '''butyrate treatment was associated with decreased aggregation of the G93A superoxide dismutase 1 mutated protein'''. ...
 
The findings from this study highlight '''the complex role of the gut microbiome and intestinal epithelium in the progression of ALS and present butyrate as a potential therapeutic reagent for restoring ALS-related dysbiosis'''."{{#pmid: 28129947|Zhang2017}}
 
  
 
==References==
 
==References==
  
 
[[Category:Key concepts]]
 
[[Category:Key concepts]]

Please note that all contributions to MyWiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see MyWiki:Copyrights for details). Do not submit copyrighted work without permission!

To protect the wiki against automated edit spam, we kindly ask you to solve the following CAPTCHA:

Cancel | Editing help (opens in new window)

Template used on this page: